Active Ingredient: CILASTATIN SODIUM; IMIPENEM
Proprietary Name: IMIPENEM AND CILASTATIN
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL;500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A091007
Product Number: 001
Approval Date: Nov 16, 2011
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information